
Aristocrom2%
Aristopharma Ltd.
Sodium Cromoglicate [2%] eye drops are indicated for the prophylactic treatment and relief of the signs and symptoms of allergic conjunctivitis and more.
Sodium Cromoglicate [2%] eye drops are indicated for the prophylactic treatment and relief of the signs and symptoms of allergic conjunctivitis, including seasonal (hay fever-related) and perennial (year-round) allergic conjunctivitis.
Sodium Cromoglicate [2%] works best when started before expected allergen exposure (e.g., before the pollen season) and used regularly; it is a preventive treatment and is not intended for rapid relief of an allergic reaction that has already started.
| Indication | Population | Dose |
|---|---|---|
| Allergic conjunctivitis (prophylaxis and treatment) | Adults and children over 6 years | Instill 1–2 drops of Sodium Cromoglicate [2%] into each eye, 4 times daily (approximately every 4–6 hours while awake) |
| Allergic conjunctivitis | Children under 6 years | Use only on medical advice; safety and efficacy not well established for this age group with this specific product |
Regular, consistent use is essential — Sodium Cromoglicate [2%] is a preventive medication and its full benefit may take several days of regular use to become apparent. It is most effective when started before anticipated allergen exposure (e.g., before pollen season) and continued throughout the period of exposure.
Do not use continuously for more than 4 weeks without medical review unless directed by a physician. If symptoms do not improve within 48 hours of regular use, or if they worsen, consult a physician.
Sodium Cromoglicate [2%] is generally very well tolerated. The most commonly reported side effects are local and transient:
Rarely, hypersensitivity reactions (e.g., eyelid swelling, itching, or contact dermatitis) can occur, in which case use should be stopped and a physician consulted. Serious adverse effects are uncommon given the drug's minimal systemic absorption.
Sodium Cromoglicate [2%] is contraindicated in patients with known hypersensitivity to sodium cromoglicate or to any excipient in the formulation (including benzalkonium chloride).
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.